V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260016775 | 260009498 | 1.62 | 75 | Palliative (P) | 2016-04-27 | 2016-05-24 | IVE | N | N | 260028633 | BEAM + ALEMTUZUMAB |
| 260016776 | 260009502 | 1.66 | 76.4 | Palliative (P) | 2017-10-27 | 2017-12-02 | Cyclophosphamide High Dose | N | N | 260028634 | METHOTREXATE HIGH DOSE |
| 260016777 | 260009503 | 1.6 | null | Palliative (P) | 2016-04-02 | 2016-04-06 | R-GDP | N | N | 260028637 | GEMCITABINE + OXALIPLATIN + RITUXIMAB |
| 260016778 | 260016948 | 1.88 | null | Curative (C) | 2018-02-20 | 2018-02-20 | R Chlorambucil | 02 | N | 260028638 | DHAP - R |
| 260016779 | 260009505 | 1.61 | 77.7 | Palliative (P) | 2015-12-26 | 2016-02-14 | Azacitidine | null | null | 260028640 | IVE |
| 260016780 | 260016949 | 1.79 | 105.4 | Disease modification (D) | 2015-02-26 | 2015-09-02 | R-EPOCH | N | N | 260028641 | FLAG + IDARUBICIN |
| 260016781 | 260009508 | 1.72 | 79.75 | Curative (C) | 2018-06-03 | 2018-06-18 | ICE + GCSF | 02 | null | 260028647 | FLUOROURACIL |
| 260016782 | 260009510 | 1.66 | 40.7 | Palliative (P) | 2014-10-04 | 2014-10-06 | Docetaxel | 02 | N | 260028654 | DOCETAXEL + TRASTUZUMAB |
| 260016783 | 260009512 | null | 75 | Curative (C) | 2018-04-06 | 2018-04-19 | Gemcitabine + Oxaliplatin | 2 | N | 260028658 | POMB |
| 260016784 | 260009513 | 1.69 | 93 | Palliative (P) | 2014-05-15 | 2014-05-15 | IFOSFAMIDE + PACLITAXEL | 02 | N | 260028659 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260016785 | 260009516 | 1.87 | 68.2 | Curative (C) | 2018-11-05 | 2018-12-28 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE | N | N | 260028702 | RMS 2005 TRIAL |
| 260016786 | 260014529 | null | 63.8 | Adjuvant (A) | 2018-01-18 | 2018-01-18 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260028717 | CHOP |
| 260016787 | 260009520 | 1.73 | 51 | Curative (C) | 2015-04-10 | 2015-04-10 | DHAP - R | N | null | 260028726 | CAPECITABINE + RT |
| 260016788 | 260009524 | 1.55 | 60.8 | Curative (C) | 2017-09-05 | 2019-05-27 | DOCETAXEL + TRASTUZUMAB | N | N | 260028735 | CISPLATIN + RT |
| 260016789 | 260009524 | 1.6 | 85.8 | Adjuvant (A) | 2016-03-12 | 2016-04-22 | TRASTUZUMAB | N | N | 260028735 | TRASTUZUMAB |
| 260016790 | 260009528 | 1.89 | 57.3 | Disease modification (D) | 2018-03-14 | 2018-03-14 | IFOSFAMIDE + PACLITAXEL | N | Y | 260028757 | GEMCARBO |
| 260016791 | 260014536 | 1.89 | 65.9 | null | 2016-05-04 | 2016-05-12 | ACE (germ cell) | null | n | 260028763 | CARBOPLATIN + ETOPOSIDE |
| 260016792 | 260009530 | 1.7 | 80.6 | Palliative (P) | 2016-04-15 | 2016-04-16 | IVA | 2 | N | 260028765 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260016793 | 260009531 | 1.88 | 94.5 | Palliative (P) | 2016-04-29 | 2016-08-18 | IPO | 02 | N | 260028772 | IFOSFAMIDE + PACLITAXEL |
| 260016794 | 260009533 | 1.74 | 66.5 | Curative (C) | null | 2015-07-03 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260028776 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260016795 | 260009535 | 1.8 | 82.4 | Curative (C) | 2014-09-20 | 2014-09-23 | CARBOPLATIN + IFOSFAMIDE + PACLITAXEL | N | N | 260028782 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260016796 | 260009536 | 1.74 | null | Palliative (P) | 2014-05-11 | 2014-05-11 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | null | 260028790 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260016797 | 260016961 | 1.87 | 74.8 | Disease modification (D) | 2013-11-10 | 2013-11-28 | GEMCITABINE + TIP | 2 | N | 260028790 | IFOSFAMIDE + PACLITAXEL |
| 260016798 | 260009544 | 1.65 | 64 | Adjuvant (A) | 2013-11-19 | 2013-11-19 | CISPLATIN + GEMCITABINE + RITUXIMAB | 2 | N | 260028798 | CVP |
| 260016799 | 260009545 | 1.59 | 61 | null | 2014-07-14 | 2014-07-22 | ICE | 2 | N | 260028814 | BLEOMYCIN + VINCRISTINE |
| 260016800 | 260009550 | 1.83 | 90.5 | Adjuvant (A) | 2014-06-09 | 2014-06-20 | ACE (germ cell) | N | N | 260028818 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260016801 | 260009552 | 1.69 | 108 | Curative (C) | 2017-01-20 | 2017-01-20 | Cyclophosphamide High Dose | N | N | 260028822 | GDP |
| 260016802 | 260009554 | 1.75 | 71.2 | Palliative (P) | 2017-08-14 | 2017-08-19 | Obinutuzumab | 2 | N | 260028828 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260016803 | 260009556 | null | null | Curative (C) | 2015-05-16 | 2015-05-16 | CARBOPLATIN + RT | 02 | null | 260028854 | CARBOPLATIN + THIOTEPA + TOPOTECAN |
| 260016804 | 260009558 | 1.74 | 78.05 | Curative (C) | null | 2016-07-11 | POMB | null | null | 260028859 | BLEOMYCIN |
| 260016805 | 260009560 | 0 | 59.7 | Curative (C) | 2016-07-13 | 2016-07-22 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260028868 | DOCETAXEL + GEMCITABINE |
| 260016806 | 260016969 | 1.88 | 72 | Adjuvant (A) | 2017-02-19 | 2017-12-19 | CARBOPLATIN + ETOPOSIDE | N | N | 260028878 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260016807 | 260009564 | 1.59 | 67.6 | Adjuvant (A) | 2018-07-28 | 2018-08-03 | BLEOMYCIN + VINCRISTINE | N | N | 260028879 | CVP |
| 260016808 | 260009567 | 1.7 | 45 | Curative (C) | 2016-04-20 | 2016-06-28 | BLEOMYCIN + VINCRISTINE | null | N | 260028892 | TRASTUZUMAB |
| 260016809 | 260009570 | 1.63 | 61 | Curative (C) | 2016-07-01 | 2016-07-16 | CVP | 2 | N | 260028899 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260016810 | 260009571 | 1.72 | 49 | Curative (C) | 2015-11-14 | 2015-11-20 | ACE (germ cell) | N | N | 260028904 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260016811 | 260009574 | 1.86 | 85.7 | Curative (C) | 2017-12-09 | 2017-12-13 | BLEOMYCIN | N | N | 260028923 | GEMCITABINE |
| 260016812 | 260009577 | 1.66 | 58.3 | Not known (9) | 2015-04-26 | 2015-08-31 | DOCETAXEL + TRASTUZUMAB | N | N | 260028934 | CISPLATIN + RT |
| 260016813 | 260009579 | 1.78 | null | Curative (C) | 2016-02-09 | 2016-02-10 | CISPLATIN + GEMCITABINE + RITUXIMAB | null | N | 260028938 | BLEOMYCIN + VINCRISTINE |
| 260016814 | 260009580 | 1.6 | 73 | Neo-adjuvant (N) | 2018-08-25 | 2018-09-01 | NIVOLUMAB | 02 | N | 260028943 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260016815 | 260009588 | 1.69 | 71.2 | Curative (C) | 2013-05-30 | 2013-06-24 | PACLITAXEL | N | N | 260028975 | ERLOTINIB |
| 260016816 | 260009589 | 1.77 | null | Curative (C) | 2017-03-27 | 2017-04-03 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260028975 | POMB |
| 260016817 | 260009591 | 1.63 | 74.5 | Palliative (P) | 2016-10-31 | 2016-11-24 | Bendamustine + Obinutuzumab | 2 | N | 260028981 | NIVOLUMAB |
| 260016818 | 260009591 | 1.71 | null | Palliative (P) | 2018-07-17 | 2018-08-09 | Gemcitabine + Oxaliplatin | N | N | 260028981 | CISPLATIN + GEMCITABINE |
| 260016819 | 260009592 | 1.8 | 85.4 | Curative (C) | 2016-02-13 | 2016-02-14 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260028990 | EP |
| 260016820 | 260009593 | null | 75.6 | null | 2018-07-28 | 2018-07-29 | NIVOLUMAB | N | N | 260028993 | NIVOLUMAB |
| 260016821 | 260009603 | 1.87 | null | Palliative (P) | 2018-12-19 | 2018-12-22 | BLEOMYCIN | N | N | 260029017 | IFOSFAMIDE + PACLITAXEL |
| 260016822 | 260016979 | 0 | 93.5 | Adjuvant (A) | 2018-08-13 | 2018-08-13 | Gemcitabine + Paclitaxel | 02 | N | 260029021 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260016823 | 260009611 | 1.58 | 94 | Curative (C) | 2014-03-02 | 2014-03-05 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 260029029 | CISPLATIN + VINORELBINE + RT |
| 260016824 | 260009613 | 1.67 | 62.6 | Palliative (P) | 2018-03-04 | 2018-04-03 | Cisplatin 7 day | N | null | 260029033 | ICE |